-
How physicians use VR to train for emergency care
Chelsea Adams Medical & Allied HealthcareRecreating the sights and sounds of a trauma bay is a challenge for doctors in training. Without witnessing it firsthand, residents may have trouble fully understanding what treating a trauma patient can entail. To introduce residents to the experience, some schools are turning to virtual reality technology to fill the gap between the classroom and the emergency department.
-
Don’t let wrist pain sideline your game
Sheilamary Koch Sports & FitnessIf you've ever injured or experienced soreness in your wrist, you know how debilitating it is. Simple tasks like turning a door knob or buttoning clothes can trigger pain — just imagine what a wrist injury could do to your workout routine or playing schedule. To avoid being sidelined by a bad wrist, here's a look at how problems start in this joint and how to sidestep them.
-
Unnecessary antibiotics: Treating the common cold
Dorothy L. Tengler Medical & Allied HealthcareAntibiotic resistance is a major concern worldwide. It has been well established that antibiotic use increases the likelihood for an individual to develop bacterial resistance. The majority of antibiotic prescribing takes place in primary care, and physicians and PAs have been encouraged to prescribe antibiotics more rationally, only when necessary.
-
Have doctors gotten a bad rap in the fight against opioids?
Cait Harrison Medical & Allied HealthcareOpioid addiction has become a sickening problem in America. The powerful pain relievers, available legally by prescription — such as oxycodone, hydrocodone, codeine, morphine, fentanyl and many others — are easy to become addicted to and even more difficult to break away from.
-
Symptom relief for worsening heart failure
Dorothy L. Tengler Medical & Allied HealthcareHeart failure (HF) is a growing problem. More than 20 million people worldwide are affected by HF, including more than 5 million in the United States alone. HF affects 6 percent to 10 percent of people over the age of 65. Although the relative incidence is lower in women than in men, women constitute at least half of the cases of HF because of their longer life expectancy.
-
WHO declares new outbreak of Ebola in Congo
Jessica Taylor Medical & Allied HealthcareBetween December 2013 and January 2015, the largest outbreak of Ebola hit West Africa and killed more than 11,000 people. Thankfully, in May of 2015, Liberia was declared Ebola-free. Sierra Leone and Guinea followed later that year, and the outbreak was over by the beginning of 2016.
-
There’s no such thing as a free lunch
Scott E. Rupp Healthcare AdministrationA new JAMA study found that physicians received $2.4 billion in industry-related payments in 2015. The authors also note that many in healthcare don't recognize a "subconscious bias" related to such interactions with products repped by industry sales associates, and that creates a great deal of tension between the industry's financial relationships and its primary mission.
-
Cultivating nurse employee engagement
Keith Carlson Healthcare AdministrationEvery nurse leader and nurse executive knows the nurses within a healthcare organization are worth their weight in gold. The nursing staff (nursing assistants, LPNs, RNs and APRNs) is the lifeblood of any organization involved in the delivery of high-quality healthcare.
-
Report: Healthcare jobs on the rise again
Scott E. Rupp Healthcare AdministrationIn a bit of a surprise, the U.S. jobs report for April showed a huge jump from the previous month — 211,000 non-farm jobs added last month, compared to 79,000 in March. The Bureau of Labor Statistics reports that the number of jobs predicted was pegged at about 185,000.
-
New drug for ALS provides hope for patients
Dr. Abimbola Farinde PharmaceuticalAmyotrophic laterals sclerosis (ALS) is regarded as a progressive neurological condition that has the ability to destroy the nerve cells and lead to complete disability in the affected individual. Given the progressive and debilitating nature of ALS, the recent approval of a new drug for treating ALS is considered to be a milestone. Edaravone (Radicava) is only the second drug to ever be approved by the U.S. Food and Drug Administration (FDA) for the treatment of ALS — and the first in more than two decades since riluzole gained FDA approval in 1995.
All Medical & Allied Healthcare Articles